| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.33 | 0.01 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.12 | 0.01 |